CORTISONE ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Cortisone Acetate patents expire, and what generic alternatives are available?
Cortisone Acetate is a drug marketed by Pharmacia And Upjohn, Watson Labs, Barr, Chartwell Molecular, Elkins Sinn, Everylife, Heather, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Panray, Purepac Pharm, Vitarine, and Whiteworth Town Plsn. and is included in eighteen NDAs.
The generic ingredient in CORTISONE ACETATE is cortisone acetate. There are seventy-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cortisone acetate profile page.
Summary for CORTISONE ACETATE
US Patents: | 0 |
Applicants: | 15 |
NDAs: | 18 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 10 |
Patent Applications: | 4,605 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CORTISONE ACETATE at DailyMed |
Recent Clinical Trials for CORTISONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |
University Medical Center Groningen | Early Phase 1 |
Assiut University | Phase 2/Phase 3 |
Pharmacology for CORTISONE ACETATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |